These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 10188308

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.
    Chang-Claude J, Andrieu N, Rookus M, Brohet R, Antoniou AC, Peock S, Davidson R, Izatt L, Cole T, Noguès C, Luporsi E, Huiart L, Hoogerbrugge N, Van Leeuwen FE, Osorio A, Eyfjord J, Radice P, Goldgar DE, Easton DF, Epidemiological Study of Familial Breast Cancer (EMBRACE), Gene Etude Prospective Sein Ovaire (GENEPSO), Genen Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland (GEO-HEBON), International BRCA1/2 Carrier Cohort Study (IBCCS) collaborators group.
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):740-6. PubMed ID: 17416765
    [Abstract] [Full Text] [Related]

  • 3. [Epidemiology of cancer of the breast].
    Ferrero JM, Namer M.
    Arch Anat Cytol Pathol; 1994 Apr; 42(5):198-205. PubMed ID: 7872810
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Apr; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen SL, Ghadirian P, Isaacs C, Weber B, Kim-Sing C, Foulkes WD, Gershoni-Baruch R, Ainsworth P, Friedman E, Daly M, Garber JE, Karlan B, Olopade OI, Tung N, Saal HM, Eisen A, Osborne M, Olsson H, Gilchrist D, Sun P, Narod SA.
    Cancer Causes Control; 2005 Aug; 16(6):667-74. PubMed ID: 16049805
    [Abstract] [Full Text] [Related]

  • 7. [Breast cancer epidemiology].
    Ravera R, Medina E, López IM.
    Rev Med Chil; 1991 Sep; 119(9):1059-65. PubMed ID: 1845101
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H.
    Maturitas; 2005 May 16; 51(1):83-97. PubMed ID: 15883113
    [Abstract] [Full Text] [Related]

  • 10. [Reproductive risk factors of breast cancer in patients attended at a second level urban hospital].
    Ortiz Mendoza CM, Galván Martínez EA.
    Ginecol Obstet Mex; 2007 Jan 16; 75(1):11-6. PubMed ID: 17542263
    [Abstract] [Full Text] [Related]

  • 11. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL.
    J Clin Oncol; 2004 Mar 15; 22(6):1055-62. PubMed ID: 14981104
    [Abstract] [Full Text] [Related]

  • 12. Fixed and modifiable risk factors for breast cancer.
    Fentiman IS.
    Int J Clin Pract; 2001 Oct 15; 55(8):527-30. PubMed ID: 11695073
    [Abstract] [Full Text] [Related]

  • 13. Alcohol consumption and incidence of benign breast disease.
    Byrne C, Webb PM, Jacobs TW, Peiro G, Schnitt SJ, Connolly JL, Willett WC, Colditz GA.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 15; 11(11):1369-74. PubMed ID: 12433713
    [Abstract] [Full Text] [Related]

  • 14. Do traditional Gail model risk factors account for increased breast cancer in women with lupus?
    Bernatsky S, Ramsey-Goldman R, Boivin JF, Joseph L, Moore AD, Rajan R, Clarke A.
    J Rheumatol; 2003 Jul 15; 30(7):1505-7. PubMed ID: 12858448
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
    Vogel VG.
    Menopause; 2008 Jul 15; 15(4 Suppl):782-9. PubMed ID: 18596599
    [Abstract] [Full Text] [Related]

  • 16. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
    Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ.
    Cancer Epidemiol Biomarkers Prev; 1999 Sep 15; 8(9):741-7. PubMed ID: 10498392
    [Abstract] [Full Text] [Related]

  • 17. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ.
    Oncologist; 1998 Sep 15; 3(2):129-130. PubMed ID: 10388095
    [Abstract] [Full Text] [Related]

  • 18. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA, Women's Health Initiative Investigators.
    J Natl Cancer Inst; 2007 Nov 21; 99(22):1695-705. PubMed ID: 18000216
    [Abstract] [Full Text] [Related]

  • 19. Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions.
    Anderson WF, Matsuno RK, Sherman ME, Lissowska J, Gail MH, Brinton LA, Yang XR, Peplonska B, Chen BE, Rosenberg PS, Chatterjee N, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Devesa SS, García-Closas M.
    Cancer Causes Control; 2007 May 21; 18(4):439-47. PubMed ID: 17216325
    [Abstract] [Full Text] [Related]

  • 20. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS, Veierød MB, Wilsgaard T, Bernstein L, Thune I.
    J Natl Cancer Inst; 2004 Aug 04; 96(15):1152-60. PubMed ID: 15292387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.